janssen science wordmark
Oncology
Oncology

IMWG recommendations for bispecific antibodies - summary infographic

 

The International Myeloma Working Group (IMWG) has provided expert consensus clinical practice guidelines for the use of bispecific antibodies for the treatment of myeloma.

Click here to learn more about adverse event management for bispecific antibodies as recommended by the IMWG.

IMWG